Senior Regulatory Drug Expert
CurrentLarry Bauer assists medical product industry and patient advocacy organization clients in a wide range of regulatory matters, including new drug and biologic development and approval issues. Mr. Bauer also prepares requests for orphan drug designation, breakthrough therapy designation, and priority review vouchers. He provides guidance on engaging patients and patient groups throughout development, with a focus on patient interactions with FDA and increasing patient engagement in the drug development process.